Guangzhou

Lonza Expands Presence in China with GE Healthcare

Lonza has expanded its presence in China by signing a deal under which GE Healthcare will deliver a KUBio off-the-shelf biologics facility to Lonza in Guangzhou.
bioprocessing bottleneck

Biomanufacturing Bottlenecks

GEN's contributing editor K. John Morrow, Jr., PhD, recently spoke with several industry leaders to discuss the issue of bottlenecks in the biopharmaceutical industry and how they can be addressed as the industry evolves.
AGC Facility

AGC Triples U.S. Biopharmaceutical Production Capacity

AGC plans to install an additional twelve 2,000L single-use animal-cell bioreactors at their Seattle AGC Biologics site, as well as establish a new contract development and manufacturing facility for microbial manufacturing.

Orchard Therapeutics to Build Out Gene Therapy Manufacturing Site in Fremont, CA

Orchard Therapeutics said it will build out a gene therapy manufacturing facility in Fremont, CA, that will employ 100 people and increase its manufacturing capabilities to support plans for an expanded pipeline. The new facility,...
Hand holding crystal ball

The Transparent CDMO: Maintaining Autonomy in Your Biomanufacturing Partnership

Sponsored Content Brought to you by Collaboration with a contract development and manufacturing organization (CDMO) can make it possible to bring your drug to market — and to patients — faster, as additional resources allow...
Business moving up

Doubling Up Operations for Speed

Sponsored Content Brought to you by In the business world, the mantra “fail fast” is often used to describe an approach where success can be achieved by knowing what to do and when to do...
syringes

Utilizing External Collaboration to Accelerate Vaccine Development

Sponsored Content Brought to you by As the pharmaceutical industry continues to look for new and innovative ways to treat disease, some companies are putting more focus on how to prevent them. Vaccine development, while...
Hand in hand climbing up

Customer Insights: Roivant Scales up Bioprocesses through a CDMO

Sponsored Content Brought to you by Having been in the industry for more than 25 years, Patrick Guertin knows that cells can be temperamental and don’t like to be rushed, but in today’s biopharma industry speed to...
People playing jenga

CDMO or No CDMO…That Is the Question

Sponsored Content Brought to you by In the business world, the mantra “fail fast” is often used to describe an approach where success can be achieved by knowing what to do and when to do...
Bristol-Myers Squibb campus in Devens, MA

Single-Use Puzzles Come with Many Pieces

Before implementing single-use technology, biomanufacturers weigh many considerations: product volumes, processing modes (batch/continuous/hybrid), cleaning requirements, and much, much more.

Recently Featured

Stay Connected

557,677FansLike
45,821FollowersFollow
Scroll Up